Rathbones Group’s bluebird bio BLUE Stock Holding History

Rathbones Group’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-94	Closed	-$207K	–	305
2018 Q1	$207K	Buy	+94	New	+$239K	0.01%	284

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rathbones Group's BLUE Position: Q2 2018 in Review

Rathbones Group sold out of bluebird bio (BLUE) in Q2 2018, closing a stake of 94 shares — an estimated $207K sold.

Rathbones Group first reported a position in BLUE in Q1 2018 and held it in 1 quarter. The position peaked at $207K in Q1 2018. 307 funds tracked by Wall St. Rank hold BLUE as of Q2 2018.

Rathbones Group reported no remaining bluebird bio position as of Q2 2018 after selling out during the quarter.
Rathbones Group sold 94 bluebird bio shares in Q2 2018, an estimated $207K.
Rathbones Group first reported a position in bluebird bio in Q1 2018 and held it in 1 quarter.
Rathbones Group's bluebird bio position peaked at $207K in Q1 2018.
307 funds tracked by Wall St. Rank held bluebird bio as of Q2 2018.

Based on Rathbones Group's 13F filing for Q2 2018, filed 16 Jul 2018.